Zafgen Raises $8.1 Million

ZafGen Inc., a Cambridge, Mass.-based developer of an obesity therapy based on the vascular targeting of adipose tissue, has secured $8.1 million of a $10.13 million funding round, according to a regulatory filing. The company previously raised over $17 million from Atlas Venture, Third Rock Ventures and GreatPoint Ventures. www.zafgen.com